Fill Finish Manufacturing Market by Product (Consumables (Prefilled Syringes (Glass, Plastic), Vial (Glass), Cartridge), Instrument (System (Stand alone, Integrated), Machine Type (Automated, Manual))), End User (CMO, Biopharma) & Region - Global Forecast to 2027
Global Revenue Growth Predictions for the Fill Finish Manufacturing Market
The global fill finish manufacturing market generated approximately $9.2 billion in revenue during 2022 and is projected to reach $15.2 billion by 2027. With a compound annual growth rate (CAGR) of 10.7% from 2022 to 2027, the market is poised for significant expansion.
The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Growth of this market includes the rising growth of the biopharmaceutical industry and the rising adoption of prefilled syringes for parenteral dosage forms.
To know about the assumptions considered for the study, Request for Free Sample Report
Fill Finish Manufacturing Market Dynamics
Driver: Rising technological advancements in fill-finish manufacturing processes
Technological advancements in aseptic fill-finish operations involve the usage of isolators and restricted-access barrier systems (RABS), which create robust sterile manufacturing environments that effectively separate human operators from the fill-finish process. Many equipment manufacturers in the fill finish manufacturing industry are focusing on the development of barrier isolation systems, which are integrated fill-finish machines capable of carrying out all stages of fill-finish processes. In contrast to barrier isolation systems, standalone equipment used in fill-finish operations is both time-consuming and expensive, thus making the entire process complex and prone to contamination. The SA25 aseptic filling workcell by Vanrx Pharma is an example of an isolated system. Owing to the benefits of isolators or RABS, many biopharmaceutical companies are adopting these machines in drug production facilities.
In traditional aseptic fill-finish processes, conventional stainless-steel systems require additional cleaning and sterilization (CIP/SIP), whereas a single-use system eliminates the critical steps of sterilization and further reduces the changeover time by simplifying end-of-batch breakdown and decontamination operations. Many pharmaceutical, biopharmaceutical, and contract manufacturing organizations are adopting single-use fill finish systems, particularly for biologics. For instance, PreVAS (Syntegon Technology GmbH) is the first completely pre-validated, pre-assembled, and pre-sterilized single-use filling system available for vial, syringe, cartridge, and ampoule filling. This is mainly because single-use systems eliminate the need for expensive and time-consuming sterilisation processes. There are also economic advantages associated with single-use systems, such as the fact that set-up and clean-down times are significantly reduced, thereby reducing labour costs. Single-use systems also help with a reduction in capital costs and chemicals used, along with minimising utilities and water. The increasing pace of technological advancements in fill-finish manufacturing processes is positively driving market growth.
Opportunity: Emerging markets
Most of the global biomanufacturing is in North America, Western Europe, Ireland, and the UK. The emergence of global biosimilars licensure pathways has helped manufacturers expand capabilities by leveraging technologies aimed at minimising costs and amortising capital investments over multiple products. Rising living standards around the world, as well as many governments' desires for local vaccines and biologics manufacturing to serve their respective populations, are driving demand for local biologics production. This is a factor that will significantly drive the demand to expand biomanufacturing capabilities from the West to emerging markets. These economies include countries across Asia, Eastern Europe, South America, and Africa—specifically, India, China, Russia, Brazil, and Malaysia. Emerging markets such as India and China will provide lucrative opportunities for players functioning in this market. This can be attributed mainly to low labour and raw material costs, rising research activity, favourable government support, and technological integration and advancements.
Restraint: High costs associated with isolators and RABs
RABS and isolators have advanced features and functionalities. The equipment provides an enclosed environment, which reduces the risk of contamination. RABS and isolators are expensive as compared to standalone systems. The average price of RABS and isolators is around USD 4.0 million to USD 8.0 million, which is high for standalone systems. This severely limits the accessibility of small businesses. In underdeveloped or developing countries, the adoption of isolators and RABS is very low as compared to standalone systems. Standalone systems are still used in small pharmaceutical and biopharmaceutical companies, R&D laboratories, and academic institutes.
Challenge: Challenges associated with maintaining sterility in a fill finish manufacturing operation
Aseptic fill-finish operations carry more risk than non-sterile processes. They require careful planning, trained personnel, and specialised facilities and equipment for process execution. Maintaining sterility is very important, as any contamination can lead to huge financial losses and have immense effects on patients' lives. In aseptic fill-finishing processes, all the components must be sterilised before use.
The consumables segment dominated the fill finish manufacturing industry, by product
On the basis of product, the fill finish manufacturing market is segmented into instruments and consumables. The consumables segment is further segmented into vials, cartridges, prefilled syringes, and other consumables. The instruments segment is further divided into systems and machines. Machines are divided into automated and semi-automated machines. Systems are further sub-segmented into integrated systems and standalone systems. The consumables segment dominated the market and is expected to be the fastest-growing segment during the forecast period. Factors driving the growth of this segment include the wide applications of vials in lyophilization and the growing use of disposable packaging for biologics.
By end user, the contract manufacturing organisations segment is expected to witness the highest growth in the fill finish manufacturing industry during the forecast period.
During the forecast period, the contract manufacturing organisations segment of the fill finish manufacturing market is expected to show the highest growth due to the rise in new entrants in the biologics manufacturing market and the growing outsourcing of fill finish manufacturing processes from small-sized biopharmaceutical companies.
Europe accounted for the largest share of the fill finish manufacturing industry during the forecast period.
The fill finish manufacturing market is divided into five major regions: Europe, North America, Asia Pacific, Latin America, the Middle East, and Africa. Europe accounted for the largest share of the market, closely followed by North America. Factors responsible for growth in the region include the growing incidence of chronic disorders and the increasing focus of major players on increasing their presence in this region.
The Asia Pacific region is expected to have the highest CAGR during the forecast period, owing to overall advancements in the biopharmaceutical industry, expertise and academic excellence, and developments in R&D infrastructure in the Asia Pacific region.
To know about the assumptions considered for the study, download the pdf brochure
The major companies operating in the fill finish manufacturing market are Becton, Dickson and Company (US), Syntegon Technology GmbH (Germany), I.M.A. (Industria Macchine Automatiche) S.p.A. (Italy), Stevanato Group (Italy), West Pharmaceutical Services, Inc. (US), OPTIMA Packaging Group GmbH (Germany), Bausch+Strobel (Germany), Groninger & Co. GmbH (Germany), and Gerresheimer AG (Germany).
Scope of the Fill Finish Manufacturing Industry
|
Report Metric |
Details |
|
Market Revenue in 2022 |
$9.2 billion |
|
Projected Revenue by 2027 |
$15.2 billion |
|
Revenue Rate |
poised to grow at a CAGR of 10.7% |
|
Market Driver |
Rising technological advancements in fill-finish manufacturing processes |
|
Market Opportunity |
Emerging Markets |
This report categorizes the fill finish manufacturing market to forecast revenue and analyze trends in each of the following submarkets:
By product
-
Consumables
-
Prefilled Syringes
- Glass PFS
- Plastic PFS
-
Vials
- Glass Vials
- Plastic Vials
- Cartridges
- Other consumables (Ampoules, Bottles, IV Bags)
-
Prefilled Syringes
-
Instruments
-
Systems
- Integrated Systems
- Standalone Systems
-
Machine Type
- Automated Machines
- Semi-automated & Manual Machines
-
Systems
By End User
- Pharmaceutical & Biopharmaceutical Companies
- Contract Manufacturing Organizations
- Other End Users such as Research & Development Laboratories and Academic Research Institutions
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Rest of Europe
-
Asia Pacific
- Japan
- China
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Recent developments of Fill Finish Manufacturing Industry
- In 2022, BD entered into an agreement with Mitsubishi Gas Chemical Company to investigate the further development of OXYCAPT, an innovation from MGC that integrates the best of plastic and glass for plastic syringes.
- In 2021, West Pharmaceutical introduced the DeltaCube Modeling Platform and NovaGuard SA Pro Safety System for 0.5 mL standard glass syringes at Interphex.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global fill finish manufacturing market?
The global fill finish manufacturing market boasts a total revenue value of $15.2 billion by 2027.
What is the estimated growth rate (CAGR) of the global fill finish manufacturing market?
The global fill finish manufacturing market has an estimated compound annual growth rate (CAGR) of 10.7% and a revenue size in the region of $9.2 billion in 2022.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 22)
1.1 STUDY OBJECTIVES
1.2 FILL FINISH MANUFACTURING INDUSTRY DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 FILL FINISH MANUFACTURING MARKET SEGMENTATION
FIGURE 2 MARKET: GEOGRAPHIC SCOPE
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 26)
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS
2.1.3 DATA TRIANGULATION
FIGURE 4 DATA TRIANGULATION METHODOLOGY
2.2 MARKET ESTIMATION METHODOLOGY
FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE-BASED ESTIMATION)
FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 2 (ESTIMATION BASED ON CONSUMABLE SEGMENTS)
2.3 MARKET GROWTH RATE PROJECTIONS
FIGURE 7 GLOBAL MARKET: CAGR PROJECTIONS
FIGURE 8 MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, OPPORTUNITIES, RESTRAINTS, AND CHALLENGES
2.4 RESEARCH ASSUMPTIONS
3 EXECUTIVE SUMMARY (Page No. - 32)
FIGURE 9 FILL FINISH MANUFACTURING MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
FIGURE 10 FILL FINISH MANUFACTURING INDUSTRY SHARE, BY END USER, 2021
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF MARKET
4 PREMIUM INSIGHTS (Page No. - 35)
4.1 FILL FINISH MANUFACTURING MARKET OVERVIEW
FIGURE 12 RISING TECHNOLOGICAL ADVANCEMENTS IN FILL-FINISH MANUFACTURING PROCESSES TO DRIVE MARKET
4.2 ASIA PACIFIC: FILL FINISH MANUFACTURING INDUSTRY, BY END USER AND COUNTRY (2021)
FIGURE 13 CONTRACT MANUFACTURING ORGANIZATIONS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021
4.3 FILL-FINISH MANUFACTURING INSTRUMENTS MARKET, BY MACHINE TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 14 AUTOMATED MACHINES WILL CONTINUE TO DOMINATE MARKET IN 2027
4.4 FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 15 PREFILLED SYRINGES SEGMENT DOMINATES FILL-FINISH CONSUMABLES MARKET IN 2022
5 MARKET OVERVIEW (Page No. - 38)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 FILL FINISH MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS
5.2.1 DRIVERS
5.2.1.1 Rising technological advancements in fill-finish manufacturing processes
5.2.1.2 Growth of biopharmaceutical industry
5.2.1.3 Rising adoption of prefilled syringes for parenteral dosage forms
5.2.2 RESTRAINTS
5.2.2.1 High cost associated with isolators/RABS
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.4 CHALLENGES
5.2.4.1 Maintaining sterility in fill-finish manufacturing operations
5.2.5 TRENDS
5.2.5.1 Growing outsourcing of fill-finish operations
5.2.5.2 Impact of COVID-19 on market
6 FILL FINISH MANUFACTURING MARKET, BY PRODUCT (Page No. - 43)
6.1 INTRODUCTION
TABLE 1 FILL FINISH MANUFACTURING INDUSTRY, BY PRODUCT, 2020–2027 (USD MILLION)
6.2 CONSUMABLES
TABLE 2 FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 3 FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 4 NORTH AMERICA: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 5 EUROPE: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 6 ASIA PACIFIC: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1 PREFILLED SYRINGES
TABLE 7 PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 8 PREFILLED SYRINGES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 9 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 10 EUROPE: PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 11 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.1 Glass prefilled syringes
6.2.1.1.1 Widespread use of glass syringes among end users to support market growth
TABLE 12 GLASS PREFILLED SYRINGES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 13 NORTH AMERICA: GLASS PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 14 EUROPE: GLASS PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 15 ASIA PACIFIC: GLASS PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1.2 Plastic prefilled syringes
6.2.1.2.1 Plastic prefilled syringes to witness highest growth during forecast period
TABLE 16 PLASTIC PREFILLED SYRINGES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 17 NORTH AMERICA: PLASTIC PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 18 EUROPE: PLASTIC PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 19 ASIA PACIFIC: PLASTIC PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.2 VIALS
6.2.2.1 Glass vials
6.2.2.1.1 Growth in biologics market to drive demand
6.2.2.2 Plastic vials
6.2.2.2.1 Limitations associated with glass vials to support market growth
TABLE 20 VIALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 21 VIALS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 22 NORTH AMERICA: VIALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 23 EUROPE: VIALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 24 ASIA PACIFIC: VIALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.3 CARTRIDGES
6.2.3.1 High adoption among insulin manufacturers
TABLE 25 CARTRIDGES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 26 NORTH AMERICA: CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 27 EUROPE: CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 28 ASIA PACIFIC: CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.4 OTHER CONSUMABLES
TABLE 29 OTHER CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 30 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 31 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 32 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 INSTRUMENTS
TABLE 33 FILL-FINISH MANUFACTURING INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
TABLE 34 NORTH AMERICA: FILL-FINISH MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 35 EUROPE: FILL-FINISH MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 36 ASIA PACIFIC: FILL-FINISH MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.1 INSTRUMENTS, BY SYSTEM TYPE
6.3.1.1 Integrated systems
6.3.1.1.1 Help in increasing productivity
6.3.1.2 Standalone systems
6.3.1.2.1 Perform single operations such as cleaning and sterilizing
TABLE 37 FILL-FINISH MANUFACTURING INSTRUMENTS MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
6.3.2 INSTRUMENTS, BY MACHINE TYPE
6.3.2.1 Automated machines
6.3.2.1.1 Increase overall productivity for fill-finish manufacturing processes
6.3.2.2 Semi-automated and manual machines
6.3.2.2.1 Used for small-batch processing and lab trials
TABLE 38 FILL-FINISH MANUFACTURING INSTRUMENTS MARKET, BY MACHINE TYPE, 2020–2027 (USD MILLION)
7 FILL FINISH MANUFACTURING MARKET, BY END USER (Page No. - 60)
7.1 INTRODUCTION
TABLE 39 GLOBAL FILL FINISH MANUFACTURING INDUSTRY, BY END USER, 2020–2027 (USD MILLION)
7.2 CONTRACT MANUFACTURING ORGANIZATIONS
7.2.1 GROWING PACE OF OUTSOURCING TO BENEFIT CMO SECTOR
TABLE 40 MARKET FOR CONTACT MANUFACTURING ORGANIZATIONS, BY REGION, 2020–2027 (USD MILLION)
TABLE 41 EUROPE: MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 42 NORTH AMERICA: MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 43 ASIA PACIFIC: MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
7.3.1 CURRENT MARKET SCENARIO INDICATES GREATER FOCUS ON DRUG R&D THAN ON FILL-FINISH SERVICES
TABLE 44 GLOBAL MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020–2027 (USD MILLION)
TABLE 45 EUROPE: MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 47 ASIA PACIFIC: MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 OTHER END USERS
TABLE 48 GLOBAL MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
TABLE 49 NORTH AMERICA: MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 50 EUROPE: MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 51 ASIA PACIFIC: MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
8 FILL FINISH MANUFACTURING MARKET, BY REGION (Page No. - 67)
8.1 INTRODUCTION
TABLE 52 GLOBAL FILL FINISH MANUFACTURING INDUSTRY, BY REGION, 2020–2027 (USD MILLION)
8.2 EUROPE
FIGURE 17 EUROPE: MARKET SNAPSHOT
TABLE 53 EUROPE: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 54 EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 55 EUROPE: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 56 EUROPE: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2.1 GERMANY
8.2.1.1 Germany to witness highest growth in Europe
TABLE 58 GERMANY: FILL FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 USD MILLION)
TABLE 59 GERMANY: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 60 GERMANY: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2.2 FRANCE
8.2.2.1 Increasing focus on developing biologics to drive demand for fill-finish technologies
TABLE 62 FRANCE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 63 FRANCE: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 64 FRANCE: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 65 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2.3 UK
8.2.3.1 Growth in biopharmaceutical industry to support market growth
TABLE 66 UK: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 67 UK: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 68 UK: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 69 UK: FILL FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
8.2.4 REST OF EUROPE
TABLE 70 REST OF EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 71 REST OF EUROPE: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 REST OF EUROPE: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 73 REST OF EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
8.3 NORTH AMERICA
TABLE 74 NORTH AMERICA: FILL FINISH MANUFACTURING INDUSTRY, BY COUNTRY, 2020–2027 USD MILLION)
TABLE 75 NORTH AMERICA: FILL FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 76 NORTH AMERICA: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 78 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
8.3.1 US
8.3.1.1 Growth in biopharmaceutical research and development activities to drive market
TABLE 79 US: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 80 US: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 US: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
8.3.2 CANADA
8.3.2.1 Rising government focus on developing patented medicines to boost market growth
TABLE 83 CANADA: FILL FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 84 CANADA: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 85 CANADA: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)
8.4 ASIA PACIFIC
FIGURE 18 ASIA PACIFIC: FILL FINISH MANUFACTURING INDUSTRY SNAPSHOT
TABLE 87 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 88 ASIA PACIFIC: FILL FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 89 ASIA PACIFIC: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 90 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
8.4.1 CHINA
8.4.1.1 Fastest-growing market for fill-finish manufacturing in Asia Pacific
TABLE 92 CHINA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 93 CHINA: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 94 CHINA: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 95 CHINA: FILL FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
8.4.2 JAPAN
8.4.2.1 Rising geriatric population and growth in biosimilars market—key growth drivers
TABLE 96 JAPAN: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 97 JAPAN: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 98 JAPAN: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 99 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
8.4.3 REST OF ASIA PACIFIC
TABLE 100 REST OF ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 101 REST OF ASIA PACIFIC: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 102 REST OF ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 103 REST OF ASIA PACIFIC: FILL FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
8.5 LATIN AMERICA
8.5.1 INCREASING NUMBER OF BIOMANUFACTURING PLANTS TO DRIVE DEMAND FOR FILL-FINISH MACHINES AND CONSUMABLES
TABLE 104 LATIN AMERICA: FILL FINISH MANUFACTURING INDUSTRY, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 105 LATIN AMERICA: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 107 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
8.6 MIDDLE EAST AND AFRICA
8.6.1 GROWTH IN BIOPHARMACEUTICALS TO DRIVE MARKET
TABLE 108 MIDDLE EAST AND AFRICA: FILL FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
TABLE 109 MIDDLE EAST AND AFRICA: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 MIDDLE EAST AND AFRICA: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 MIDDLE EAST AND AFRICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9 COMPETITIVE LANDSCAPE (Page No. - 94)
9.1 OVERVIEW
9.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
TABLE 112 KEY DEVELOPMENTS IN FILL FINISH MANUFACTURING MARKET, 2019–2022
9.3 FILL FINISH MANUFACTURING INDUSTRY SHARE ANALYSIS
FIGURE 19 COMPANY RANKING IN FILL-FINISH CONSUMABLES MARKET, 2021
FIGURE 20 MARKET SHARE ANALYSIS IN FILL-FINISH INSTRUMENTS MARKET, 2021
9.4 COMPANY EVALUATION QUADRANT
9.4.1 STARS
9.4.2 EMERGING LEADERS
9.4.3 PERVASIVE PLAYERS
9.4.4 PARTICIPANTS
FIGURE 21 FILL FINISH MANUFACTURING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
9.5 COMPETITIVE SITUATION AND TRENDS
9.6 COMPETITIVE SCENARIO
TABLE 113 PRODUCT LAUNCHES
TABLE 114 DEALS
10 COMPANY PROFILES (Page No. - 102)
10.1 MAJOR PLAYERS
(Business Overview, Products & Services Offered, Recent Developments, and MnM View)*
10.1.1 SYNTEGON TECHNOLOGY GMBH
TABLE 115 SYNTEGON TECHNOLOGY GMBH: BUSINESS OVERVIEW
10.1.2 I.M.A. (INDUSTRIA MACCHINE AUTOMATICHE) S.P.A
TABLE 116 I.M.A. (INDUSTRIA MACCHINE AUTOMATICHE) S.P.A: BUSINESS OVERVIEW
10.1.3 BECTON, DICKINSON AND COMPANY (BD)
TABLE 117 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
FIGURE 22 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
10.1.4 STEVANATO GROUP
TABLE 118 STEVANATO GROUP: BUSINESS OVERVIEW
FIGURE 23 STEVANATO GROUP: COMPANY SNAPSHOT (2021)
10.1.5 WEST PHARMACEUTICAL SERVICES
TABLE 119 WEST PHARMACEUTICAL SERVICES: BUSINESS OVERVIEW
FIGURE 24 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT (2021)
10.1.6 OPTIMA PACKAGING GROUP GMBH
TABLE 120 OPTIMA PACKAGING GROUP GMBH: BUSINESS OVERVIEW
10.1.7 BAUSCH+STRÖBEL
TABLE 121 BAUSCH+STRÖBEL: BUSINESS OVERVIEW
10.1.8 GRONINGER & CO. GMBH
TABLE 122 GRONINGER & CO. GMBH: BUSINESS OVERVIEW
10.1.9 SGD PHARMA
TABLE 123 SGD PHARMA: BUSINESS OVERVIEW
10.1.10 SCHOTT AG
TABLE 124 SCHOTT AG: BUSINESS OVERVIEW
FIGURE 25 SCHOTT AG: COMPANY SNAPSHOT (2021)
10.1.11 GERRESHEIMER AG
TABLE 125 GERRESHEIMER AG: BUSINESS OVERVIEW
FIGURE 26 GERRESHEIMER AG: COMPANY SNAPSHOT (2021)
10.1.12 NIPRO CORPORATION
TABLE 126 NIPRO CORPORATION: BUSINESS OVERVIEW
FIGURE 27 NIPRO CORPORATION: COMPANY SNAPSHOT (2021)
10.1.13 BAUSCH ADVANCED TECHNOLOGY GROUP
TABLE 127 BAUSCH ADVANCED TECHNOLOGY GROUP: BUSINESS OVERVIEW
10.1.14 VANRX PHARMASYSTEMS INC.
TABLE 128 VANRX PHARMASYSTEMS INC.: BUSINESS OVERVIEW
10.1.15 MAQUINARIA INDUSTRIAL DARA SL
TABLE 129 MAQUINARIA INDUSTRIAL DARA SL: BUSINESS OVERVIEW
* Business Overview, Products & Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
10.2 OTHER COMPANIES
10.2.1 MARCHESINI GROUP S.P.A.
TABLE 130 MARCHESINI GROUP S.P.A.: COMPANY OVERVIEW
10.2.2 STERILINE S.R.L
TABLE 131 STERILINE S.R.L: COMPANY OVERVIEW
10.2.3 AST
TABLE 132 AST: COMPANY OVERVIEW
10.2.4 REAGENT CHEMICAL & RESEARCH, INC.
TABLE 133 REAGENT CHEMICAL & RESEARCH, INC.: COMPANY OVERVIEW
10.2.5 ASEPTIC TECHNOLOGIES
TABLE 134 ASEPTIC TECHNOLOGIES: COMPANY OVERVIEW
11 APPENDIX (Page No. - 150)
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 CUSTOMIZATIONS OPTIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS
The study involved two major activities in estimating the current market size of the fill-finish manufacturing market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.
Secondary Research
The secondary sources referred for this research study include publications from government sources, such as the World Health Organization (WHO), US Food and Drug Administration (FDA), National Institutes of Health (NIH), International Society for Pharmaceutical Engineering (ISPE), Parenteral Drug Association (PDA), BioPharm International, and the National Center for Biotechnology Information (NCBI). Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines & research journals; press releases; and trade, business, and professional associations, among others. Secondary data was collected and analyzed to arrive at the overall size of the global fill-finish manufacturing market, which was validated through primary research. The key secondary sources referred to during the preparation of this report are listed below:
Government and Intergovernmental Sources & Databases: World Health Organization (WHO), US Food and Drug Administration (FDA), National Institutes of Health (NIH), International Society for Pharmaceutical Engineering (ISPE), Parenteral Drug Association (PDA), BioPharm International, and the National Center for Biotechnology Information (NCBI), among others.
Company Sources: Annual reports, SEC filings, regulatory filings, investor presentations, press releases, and financial statements, among others.
Background Study
- Building a basic understanding of the fill-finish manufacturing market
- Analyzing the MarketsandMarkets data repository, followed by drawing and updating data tables using current information
- Identifying data gaps and key global players in product and end user segments
Market Understanding
- Identifying stakeholders and key decision-makers in different regions
- Identifying the selection criteria of key decision-makers
- Analyzing the competitive landscape
- Identifying major players with their product portfolios
- Analyzing strategies adopted by players to position different types of products
- Analyzing the regional/country-level markets
Trends
- Identifying and analyzing key products and trends to draw notes and include considerations in the final forecasts
- Identifying the major drivers, opportunities, and challenges prevailing in the fill-finish manufacturing market
- Identifying industry trends
- Analyzing the regulatory landscape
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global fill-finish manufacturing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as personnel from biopharma & pharma companies, clinical laboratories, and academic & research institutes; and purchase managers in healthcare provider organizations) and supply-side (such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners, among others) across four major regions—North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews. A breakup is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The revenue-based approach individually for instrument and consumable segments was used to estimate the global market size of the fill-finish manufacturing market.
Data Triangulation
After arriving at the overall market size—using the market size estimation processes explained above—the fill-finish manufacturing market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides of the sterile filtration market.
Report Objectives
- To define, describe, segment, and forecast the global fill-finish manufacturing market by product, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market such as drivers, restraints, opportunities, industry-specific challenges, and trends
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall fill-finish manufacturing market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To forecast the size of the fill-finish manufacturing market with respect to five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To strategically profile the key players in the market and comprehensively analyze their market rankings and core competencies
- To track and analyze competitive developments such as acquisitions, agreements, collaborations, partnerships, product launches, and expansions in the fill-finish manufacturing market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the fill-finish manufacturing market report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of the top five companies
Geographic Analysis
- Further breakdown of Latin America o Brazil and Mexico
- Further breakdown of the European fill-finish manufacturing market into Spain and Italy
Company Information
- Detailed analysis and profiling of additional market players (Up to 5)
Generating Response ...
Growth opportunities and latent adjacency in Fill Finish Manufacturing Market